BriefTea
Every story in sixty words
Get the free app no ads · no paywallHealth · 14 May 2026
Unsplash / Diana Polekhina
Thousands of cancer patients will now receive a quick, one-minute injection, replacing a two-hour intravenous hospital infusion. The NHS has rolled out this new immunotherapy jab, known as pembrolizumab, for tens of thousands of people across England. This treatment, given every three weeks, is set to help individuals battling 14 different types of cancer.
Reported by Mirror · How we write briefs
More briefs
HealthMany NHS Trusts Turn Down Palantir's Patient Data Platform TechnologyRussian Suspect in Deadly London Hospitals Hack Held in Germany HealthGreat Ormond Street's Same-Day Test Finds Hidden Infections in Sick Children HealthImmune cell found to kill small cell lung cancer in lab tests HealthDiabetics sleeping 8+ hours face nearly double kidney disease risk HealthNo perfect age to start HRT, but benefits peak before 60, experts say More health stories → Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.